Document is current
Any future updates will be listed below
-
Authors
Uzawa, Akiyuki https://orcid.org/0000-0001-9252-1863
Ozawa, Yukiko
Yasuda, Manato
Onishi, Yosuke
Akamine, Hiroyuki
Kuwabara, Satoshi
-
Funding
Funding for this research was provided by:
Health and Labor Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labor and Welfare of Japan (20FC1030)
- License Information
-
More Information
Article History
Received: 9 August 2022
Accepted: 7 December 2022
First Online: 2 January 2023
Declarations
:
: AU has received honoraria from Alexion Pharmaceuticals and Argenx. Other authors have no conflicts of interest to declare.
: Patients were enrolled via an opt-out methodology. This study protocol and the opt-out method were approved by the ethics committee of Chiba University (IRB No. 2266). We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.
